subscribe
 

Scientists develop new strategy to overcome drug-resistant childhood cancer

A new drug combination could offer hope to children with neuroblastoma – one of the deadliest forms of childhood cancer – by boosting the effectiveness of a promising new gene-targeted treatment.

US-Kent research aims to find a new treatment for migraine

A University of Kent-led clinical trial that aims to discover a potential new treatment for migraine through non-invasive neuro-stimulation is set to commence during late summer 2012.

University of Cambridge launches Open Innovation drug discovery initiative with GSK

The University of Cambridge is embarking on a programme of scientific open collaboration with GlaxoSmithKline (GSK) that will involve working alongside GSK scientists and other partner organisations, to advance drug discovery and the...

Roche and Seaside Therapeutics announce landmark alliance

Roche and Seaside Therapeutics announced that they have entered into a collaboration to develop disease modifying treatments for fragile X syndrome (FXS) and autism spectrum disorders (ASD), both neurodevelopmental disorders for which there...

Kill the germs, spare the ears

Study shows how to create effective antibiotics that don’t damage hearing.

Genetic discovery unlocks biosynthesis of medicinal compound in poppy

Scientists at the University of York and GlaxoSmithKline (GSK) Australia have discovered a complex gene cluster responsible for the synthesis of the medicinal compound noscapine.

Hepatitis C 'switch' offers target for new drug research

Scientists have discovered a 'switch' in the Hepatitis C virus which could be used as a target for new kinds of drug treatment.

Pages

Newsbrief

Twitter Icon © Setform Limited
subscribe